Fabiola Carrara is an expert in Nephrology at University of Bergamo (Italy). Fabiola Carrara has authored 58 publications, the most recent in 2026, and is an investigator in 10 clinical trials. SLR score: 137 (community average: 125). How the SLR is computed.

LeadR Profile

Fabiola Carrara University of Bergamo Italy
137 ScienceLeadR Reputation 137
Network Map

Nephrology

Subspecialties: Urology - Public Health - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2016 - 2021

Source: PubMed

University of Bergamo

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 58

Citations

Citations: 2 610 1st author: 6 Last author: 1 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Randomized Controlled Clinical Trial of Allogeneic Mesenchymal Stromal Cell Infusion in Diabetic Kidney Disease.
PMID 42433663 — kidney diseases, cells, glomerular filtration rate, diabetic nephropathies, stem cells, kidney, stromal cells, diabetes mellitus, type 2
Kidney Int Rep20260
Prospective Cohort Study of Felzartamab in Rituximab-Resistant Primary Membranous Nephropathy.
PMID 42027554 — glomerulonephritis, membranous, cells, proteinuria, cohort studies, rituximab, nephrotic syndrome, therapeutics, plasma
Kidney Int Rep20260
Prospective Cohort Study of Obinutuzumab in Rituximab-Resistant Primary Membranous Nephropathy.
PMID 41624448 — glomerulonephritis, membranous, cells, proteinuria, antibodies, cohort studies, rituximab, nephrotic syndrome, therapeutics
Kidney Int Rep20250
Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKD.
PMID 41141510 — proteinuria, therapeutics, plasma
Kidney Int Rep20250
Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression.
PMID 40237639 — kidney diseases, kidney, nephrology, therapeutics
Clin J Am Soc Nephrol20250

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 5
Phase 2 3
Phase 1/Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 8
Active not recruiting 1
Terminated 1

By type:

Interventional 10

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 2
multicentric5to9 6
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map